ハイコンテントスクリーニング（HCS）の世界市場予測（～2022年）：細胞画像・分析システム、フローサイトメトリー、ソフトウェア、サービス...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.4 Years Considered for the Study
1.5 Limitations
1.6 Currency
1.7 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Approach
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.3.1 Data From Secondary Sources
2.3.2 Data From Primary Sources
2.3.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 28)

4 Premium Insights (Page No. – 32)
4.1 High-Content Screening: Market Snapshot
4.2 Europe: High-Content Screening Market, By Application (2016)
4.3 Geographic Snapshot of the High-Content Screening Market
4.4 High-Content Screening Market: Regional Mix

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Key Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Need for Cost Containment in Pharmaceutical R&D
5.2.1.2 Government Funding and Venture Capital Investments Across Developed Markets
5.2.1.3 Advancements in Informatics Solutions and Imaging Instruments
5.2.2 Market Restraints
5.2.2.1 Lower Adoption of HCS Instruments Due to Their High Prices
5.2.3 Market Opportunities
5.2.3.1 Increasing Number of Cros Providing HCS Services
5.2.3.2 Application of HCS in Personalized Medicine
5.2.4 Market Challenges
5.2.4.1 Dearth of Knowledgeable and Skilled Operators of HCS Instruments
5.2.4.2 Inadequate Infrastructure and Funding for R&D in Emerging Countries

6 Industry Insights (Page No. – 44)
6.1 Industry Trends
6.1.1 Rising Adoption of Label-Free Technologies
6.1.2 Growing Focus on Stem Cell Analysis
6.2 Technological Roadmap

7 Global High-Content Screening Market, By Product (Page No. – 47)
7.1 Introduction
7.2 Instruments
7.2.1 Cell Imaging and Analysis Systems
7.2.2 Flow Cytometers
7.2.2.1 Cell Analyzers
7.2.2.2 Cell Sorters
7.3 Consumables
7.3.1 Reagents & Assay Kits
7.3.2 Microplates
7.3.3 Other Consumables
7.4 Software
7.5 Services
7.6 Accessories

8 Global High-Content Screening Market, By Application (Page No. – 63)
8.1 Introduction
8.2 Primary and Secondary Screening
8.3 Target Identification and Validation
8.4 Toxicity Studies
8.5 Compound Profiling
8.6 Other Applications

9 Global High-Content Screening Market, By End User (Page No. – 70)
9.1 Introduction
9.2 Pharmaceutical and Biotechnology Companies
9.3 Academic and Government Institutes
9.4 Contract Research Organizations

10 High-Content Screening Market, By Region (Page No. – 75)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Switzerland
10.3.5 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Latin America
10.6 Middle East and Africa

11 Competitive Landscape (Page No. – 117)
11.1 Overview
11.2 Competitive Analysis
11.2.1 Market Players Ranking
11.2.2 Product Matrix
11.2.3 Vendor Benchmarking
11.3 Competitive Situations and Trends
11.3.1 Product Launches
11.3.2 Collaborations, Partnerships, and Agreements
11.3.3 Acquisitions
11.3.4 Expansions

12 Company Profiles (Page No. – 128)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 GE Healthcare
12.3 Danaher Corporation
12.4 Perkinelmer, Inc.
12.5 Thermo Fisher Scientific Inc.
12.6 Becton, Dickinson and Company
12.7 Biotek Instruments, Inc.
12.8 Bio-Rad Laboratories, Inc.
12.9 Tecan Group Ltd.
12.10 Yokogawa Electric Corporation
12.11 Merck Millipore

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 154)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details